Clinical Trials Data Dermatologist-Reported Results in 8 Weeks 81% experienced healthier overall skin* 71% saw improved hydration* 78% noticed reduced redness* In just 8 weeks: 78% saw reduced skin redness^ *Protocol: Clinically tested with dermatologist evaluation on 35 participants, ages 30-60, applying twice daily for 8 weeks
Our free calculators are designed to help patients understand common peptide terminology before or during treatment
This form is used specifically for oral delivery due to its improved stability compared to acetate versions which are typically intended for injectable use

Safety, Tolerability & Regulatory Status Safety Profile GHK-Cu demonstrates an excellent safety profile for cosmetic use: Naturally occurring in humans (plasma, saliva, urine) Non-sensitizing in standard patch testing at cosmetic concentrations Long history of topical application in anti-aging and wound care products Minimal reported adverse reactions at appropriate doses Usage Levels and Tolerability Regulatory Status EU : Permitted as a cosmetic ingredient with standard safety assessments US/Asia-Pacific : Allowed under respective cosmetic regulations Formulators must : Perform product-specific safety evaluations, including SDS review, toxicological profiles, and margin of safety calculations Addressing Copper Uglies Literature occasionally references theoretical over-stimulation of MMPs leading to collagen breakdown (sometimes called copper uglies)
doi:10.1016/0003-2697(88)90564-7